Heart, Lung and Circulation
Volume 18, Issue 6 , Pages 393-400 , December 2009

p38 Mitogen-Activated Protein Kinase Inhibition Reduces Inflammatory Cytokines in a Brain-Dead Transplant Donor Animal Model

  • Takahiro Oto, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Alfred Hospital, and Department of Surgery, Monash University, Melbourne, Australia
    • ,
  • Alicia Calderone, BBiomedSc(Hons)

      Affiliations

    • Department of Cardiothoracic Surgery, Alfred Hospital, and Department of Surgery, Monash University, Melbourne, Australia
    • ,
  • Zhihe Li, MD, PhD

      Affiliations

    • Department of Pharmacology and Preclinical Research, Scios Inc., Fremont, CA, USA
    • ,
  • Franklin L. Rosenfeldt, MD, FRACS

      Affiliations

    • Department of Cardiothoracic Surgery, Alfred Hospital, and Department of Surgery, Monash University, Melbourne, Australia
    • ,
  • Salvatore Pepe, PhD, FAHA, FCSANZ

      Affiliations

    • Department of Cardiothoracic Surgery, Alfred Hospital, and Department of Surgery, Monash University, Melbourne, Australia
    • Corresponding Author InformationCorresponding author at: Department of Cardiology, Royal Children's Hospital, Flemington Road, Melbourne, VIC 3052, Australia. Tel.: +61 393454114; fax: +61 3 9345 6001.

Received 5 February 2008 ,Revised 19 March 2009 ,Accepted 12 May 2009.

References 

  1. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995;333:333–336
  2. Van der Hoeven JA, Lindell S, van Schilfgaarde R, Molema G, Ter Horst GJ, Southard JH, et al. Donor brain death reduces survival after transplantation in rat livers preserved for 20h. Transplantation. 2001;72:1632–1636
  3. Wilhelm MJ, Pratschke J, Beato F, Taal M, Kusaka M, Hancock WW, et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation. 2000;102:2426–2433
  4. Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation. 2003;75:1928–1933
  5. Pratschke J, Wilhelm MJ, Kusaka M, Basker M, Cooper DK, Hancock WW, et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation. 1999;67:343–348
  6. Rosner MJ, Newsome HH, Becker DP. Mechanical brain injury: the sympathoadrenal response. J Neurosurg. 1984;61:76
  7. Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation. 1998;65:1533–1542
  8. Segel LD, vonHaag DW, Zhang J, Follette DM. Selective overexpression of inflammatory molecules in hearts from brain-dead rats. J Heart Lung Transplant. 2002;21:804–811
  9. Amado JA, Lopez-Espadas F, Vazquez-Barquero A, Salas E, Riancho JA, Lopez-Cordovilla JJ, et al. Blood level of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants. Metabolism. 1995;44:812–816
  10. Fisher AJ, Donnelly SC, Hirani N, Haslett C, Strieter RM, Dark JH, et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med. 2001;163:259–265
  11. Birks EJ, Owen VJ, Burton PB, Bishop AE, Banner NR, Khaghani A, et al. Tumor necrosis factor-α is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation. 2000;102:326
  12. Kumar S, Boehm J, Lee JC. P38 MAPKs: key signaling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov. 2003;2:717–726
  13. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808–811
  14. Wang M, Tsai BM, Turrentine MW, Mahomed Y, Brown JW, Meldrum DR. p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart. Ann Thorac Surg. 2005;80:2235–2241
  15. Lim MY, Wang H, Kapoun AM, O’connell M, O’Young G, Brauer HA, et al. p38 inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells. J Mol Cell Cardiol. 2004;37:1111–1114
  16. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81:807–869
  17. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, et al. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. P38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res. 1996;79:162–173
  18. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, et al. Pro-inflammatory cytokines and enviromental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 1995;270:7420
  19. Meldrum DR, Dinarello CA, Cleveland JC, Cain BS, Shames BD, Meng X, et al. Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a p38 mitogen-activated protein kinase-dependent mechanism. Surgery. 1998;124:291–296
  20. Cain BS, Meldrum DR, Meng X, Pulido EJ, Shames BD, Selzman CH, et al. p38 MAPK inhibition decreases TNF-alpha production and enhances postischemic human myocardial function. J Surg Res. 1999;83:7–12
  21. Mackay K, Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem. 1999;274:6272
  22. Hashimoto N, Takeyoshi I, Yoshinari D, Tsutsumi H, Tokumine M, Totsuka O, et al. Effect of a p38 mitogen-activated protein kinase inhibitor as an additive to Euro-Collins solution on reperfusion injury in canine lung transplantation. Transplantation. 2002;74:320–326
  23. Li Z, Tran TT, Ma JY, O’Young G, Kapoun AM, Chakravarty S, et al. P38α mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J Cardiovasc Pharmacol. 2004;44:486–492
  24. Duffy JY, Nelson DP, Schwartz SM, Wagner CJ, Bauer SM, Lyons JM, et al. Glucocorticoids reduce cardiac dysfunction after cardiopulmonary bypass and circulatory arrest in neonatal piglets. Pediatr Crit Care Med. 2004;5:28–34
  25. Svensson CI, Marsala M, Westerlund A, Calcutt NA, Campana WM, Freshwater JD, et al. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem. 2003;86:1534–1544
  26. Clerk A, Sugden PH. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett. 1998;426:93–96
  27. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun. 1997;235:533–538
  28. Bittner HB, Kendall SW, Chen EP, Van Trigt P. The combined effects of brain death and cardiac graft preservation on cardiopulmonary hemodynamics and function before and after subsequent heart transplantation. J Heart Lung Transplant. 1996;15:764–777
  29. Ryan JB, Hicks M, Cropper JR, Garlick SR, Kesteven SH, Wilson MK, et al. Functional evidence of reversible ischemic injury immediately after the sympathetic storm associated with experimental brain death. J Heart Lung Transplant. 2003;22:922–928
  30. Szabo G. Physiologic changes after brain death. J Heart Lung Transplant. 2004;23(9 Suppl.):S223–S226
  31. Birks EJ, Owen VJ, Burton PB, Bishop AE, Banner NR, Khaghani A, et al. Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation. 2000;102:352–358
  32. Plenz G, Eschert H, Erren M, Wichter T, Bohm M, Flesch M, et al. The interleukin-6/interleukin-6-recepter system is activated in donor hearts. J Am Coll Cardiol. 2002;39:1508–1512
  33. Li M, Georgakopoulos D, Lu G, Hester L, Kass DA, Hasday J, et al. P38 MAP kinase mediates inflammatory cytokine induction in cardiomyocites and extracellular matrix remodeling in heart. Circulation. 2005;111:2494–2502
  34. Avlonitis VS, Wigfield CH, Kirby JA, Dark JH. Hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant. 2005;5:684–693
  35. Skrabal CA, Thompson LO, Potapov EV, Southard RE, Joyce DL, Youker KA, et al. Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death. J Surg Res. 2005;123:118–125
  36. Li Z, Ma JY, Kerr I, Chakravarty S, Dugar S, Schreiner G, et al. Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury. Am J Physiol. 2006;291:H1972–H1977
  37. Koppelman B, Webb HK, Medicherla S, Almirez R, Feng Y, Chavez JC, et al. Pharmacological properties of SD-282—an alpha-isoform selective inhibitor for p38 MAP kinase. Pharmacology. 2008;81:204–220
  38. Watanabe K, Ma M, Wen J, Kodama M, Aizawa Y. Effects of edaravone in heart of aged rats after cerebral ischemia-reperfusion injury. Biol Pharm Bull. 2007;30:460–464
  39. Zhou HC, Ding WG, Cui XG, Pan P, Zhang B, Li WZ. Carbon monoxide inhalation ameliorates conditions of lung grafts from rat brain death donors. Chin Med J (Engl). 2008;121:1411–1419

PII: S1443-9506(09)00946-9

doi: 10.1016/j.hlc.2009.05.706

Heart, Lung and Circulation
Volume 18, Issue 6 , Pages 393-400 , December 2009

Article Tools

* Image Usage & Resolution